Earth Science Tech, Inc., Reports Record Fiscal Q1 2023 Financial Results

“Strategy is important, execution is everything.”

Miami, FL, July 28, 2023 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a holding entity currently focused on the health and wellness industry, today shares financial results, highlights, and outlook from record fiscal Q1 2023 report, quarter ended June 30, 2023.

Financial Results:

As of June 30, 2023, the Company recorded:

• $91,989 in cash, a 352.63% increase compared to the quarter ended June 30, 2022, and a 157% increase compared to the year ended March 31, 2023.
  
• $2,752,719 in assets, a 759% increase compared to the quarter ended June 30, 2022, and a 2.25% increase compared to the year ended March 31, 2023.
  
• $219,934 in revenue, versus $0 in the quarter ended June 30, 2022, and a 353.13% increase compared to the year ended March 31, 2023.
  
• $148,769 in gross profit, versus $0 in the quarter ended June 30, 2022, and a 574.38% increase compared to the year ended March 31, 2023.
  
• $1,263,660 in liabilities, a 44.59% decrease compared to the quarter ended June 30, 2022, and a 21.44% decrease compared to the year ended March 31, 2023.
  
• $1,489,059 in Stockholders Equity, a 175.97% increase compared to the quarter ended June 30, 2022, and a 37.40% increase compared to the year ended March 31, 2023.
  

Highlights:

• In April 2023, RxCompoundStore.com, LLC. (“RxCompound”) created ViagraMia.com and MySexGummy.com to diversify its men’s health sales channels by offering rapid online telehealth consultations and fulfillment of ED prescriptions.
  
• In May 2023, the Company created DocProtocol.com (“DocProtocol”) to offer patient specific protocols to doctors and wellness centers for their patients. The protocols are developed by highly respected functional medicine professionals, and we expect the majority of the prescriptions generated by DocProtocol will be fulfilled by RxCompound.
  
• In May 2023, RxCompound created ClearUpSkinCare.com to develop and offer medical grade skincare products.
  
• In May 2023, RxCompound received approval for its sterile compounding lab and began operations, including sales of sterile injectable prescriptions.
  
• In June 2023, Peaks Curative, LLC. (“Peaks”) created MyOnlineConsultation.com (“MOC”) a patient to doctor referral platform to facilitate consultations for compounded prescription medications. Through MOC’s doctor network, patients will be able to obtain prescriptions for compounded medications for men’s health, women’s health, hair and skin care, and weight loss filled by RxCompound.

Outlook: